AstraZeneca
AZN
#55
Rank
โ‚ฌ258.05 B
Marketcap
166,39ย โ‚ฌ
Share price
-2.56%
Change (1 day)
37.86%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ258.05 Billion

As of July 2026 AstraZeneca has a market cap of โ‚ฌ258.05 Billion. This makes AstraZeneca the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ258.05 B5.3%
2025โ‚ฌ245.05 B25.25%
2024โ‚ฌ195.66 B3.4%
2023โ‚ฌ189.22 B-3.52%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-4.92%
2011โ‚ฌ46.60 B-4.74%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On Jul 6th, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ516.07 Billion
by Nasdaq info icon info icon
โ‚ฌ258.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ546.23 B 111.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ259.60 B 0.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ118.29 B-54.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ145.74 B-43.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ936.37 B 262.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ89.24 B-65.41%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ26.92 B-89.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ273.98 B 6.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ101.31 B-60.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ93.03 B-63.95%๐Ÿ‡ฌ๐Ÿ‡ง UK